Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. BWAY
BWAY logo

BWAY

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

BWAY News

BRAINSWAY FINALIZES $6 MILLION MILESTONE-BASED INVESTMENT IN NEUROLIEF LTD. AFTER FDA APPROVAL OF PROLIV™RX SYSTEM FOR MDD

4d agomoomoo

BrainsWay Completes $6 Million Investment in Neurolief Following FDA Approval

4d agoNewsfilter

Major Averages Decline Amid Oil Price Volatility

Mar 12 2026Yahoo Finance

Wall Street Analysts Adjust MU Stock Ratings

Mar 12 2026Benzinga

BrainsWay Ltd Reports Strong 2025 Earnings Growth

Mar 11 2026Yahoo Finance

BrainsWay Shares Surge to All-Time High After Strong Q4 2025 Results

Mar 11 2026seekingalpha

BrainsWay Q4 Earnings Beat Expectations, 2026 Outlook Positive

Mar 11 2026seekingalpha

BrainsWay to Announce Q4 Earnings on March 11

Mar 10 2026seekingalpha

GAD Therapies Market Expected to Reach $4.26B by 2033 Amid Rising Demand

Mar 05 2026PRnewswire

GAD Therapies Market Expected to Reach $4.26B by 2033 Amid Rising Demand

Mar 05 2026Newsfilter

Investment Opportunities in Oversold Healthcare Stocks

Mar 05 2026Benzinga

BrainsWay Unveils New Noninvasive Depression Treatment Protocol

Mar 04 2026Newsfilter

BrainsWay to Report Q4 and Full Year 2025 Results on March 11

Feb 25 2026Yahoo Finance

BrainsWay Makes $2.5M Investment in BrainStim Health

Feb 19 2026seekingalpha

BrainsWay Enters Strategic Investment Agreement with BrainStim Health

Feb 19 2026Newsfilter

BrainsWay Shares Rise as Cigna Removes TMS Authorization Requirements

Feb 18 2026seekingalpha